Stocks Analysis by Zacks Investment Research covering: AbbVie Inc. Read Zacks Investment Research's latest article on Investing.com Why AbbVie (ABBV) Stock Is Down Today. AbbVie, Inc. ABBV stock has declined 20.8% this year so far against an increase of 2.9% recorded by the industry. 76.4% of retail CFD accounts lose money. On the stock market today, though, AbbVie gained 3.6% to close at 103.01, after announcing the preliminary results of its modified Dutch auction tender offer. AbbVie, Inc. (ABBV Quick Quote ABBV - Free Report) stock has declined 20.8% this year so far against an increase of 2.9% recorded by the industry. Coherus stock is up nearly 17% this afternoon. NEW YORK (TheStreet) -- AbbVie (ABBV) - Get Report stock is tumbling 4.20% to $59.83 on heavy trading volume early Tuesday afternoon, as one of its patents on its top-selling arthritis drug Humira might be invalid, according to the U.S. Patent and Trademark office. Shares of AbbVie (ABBV) fell in morning trading Tuesday after the U.S. Treasury Department and … The company is alleging that AbbVie's patent is invalid since the dosage regimen it covers was a "routine optimization of the therapy" that was known by researchers, Bloomberg adds. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. AbbVie (ABBV) stock is lower in early-afternoon trading on Tuesday as its Humira patent might be invalid and Paulson & Co. dissolved its stake in the company. Read Why Roku Stock Fell after Its Q4 Earnings to learn more. See all the holdings with a free trial.). AbbVie (NYSE: ABBV) stock took a hit today following comments concerning biosimilars. With many stocks at all-time highs, the bar for 2020 is extremely high and it gets more and more difficult to find stocks at attractive valuations. A decision in the case is expected later this year. News More News. From a technical standpoint, the stock broke down from a long-term descending triangle to trendline support dating back to 2017. Additionally, Paulson & Co. exited its stake in AbbVie as of March 31. Coherus has demonstrated a "reasonable likelihood" that it will win the challenge, according to the Patent Trial and Appeal Board,Bloomberg reports. Author: Rachel Graf This is due to AbbVie’s acquisition of Allergan back in May. Also, the S&P … Now what AbbVie spent $5.8 billion to acquire Stemcentrx in 2016 mostly because it … Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. By Nov. 1, 2018, AbbVie stock had fallen 35% from its peak earlier in the year and at recent prices, it's given up just 5.4% so far in 2018. AbbVie (ABBV) stock is lower in early-afternoon trading on Tuesday as its Humira patent might be invalid and Paulson & Co. dissolved its stake in the company. 107.15 +1.88 +1.79% Official Close 12/31/2020 NYSE. 8:48p U.S. stock futures down slightly as 2021 trading kicks off 8:12p XPeng Is the Latest EV Company to Report Positive Delivery News Cramer said investors can "shop the drop" and pick up great stocks as they head lower, but only if they fit one of his 10 investable themes for 2021. Add to watchlist Start Trading >> Plus500. Why AbbVie Stock Is Sinking and Allergan Is Soaring Today ... would make a deal that would reenergize the stock. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this article's author. AbbVie's stock traded down 4.20% at $91.75 per share at the time of publication on Tuesday. On big down days in the stock market, Jim Cramer told Mad Money viewers Monday night, you can always fall back on long-term bullish themes. Separately, TheStreet Ratings team rates the stock as a "buy" with a ratings score of A. AbbVie's strengths such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and expanding profit margins outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Today’s selloff adds to recent headaches for AbbVie, which has seen its share price slump by nearly 20% since reaching new highs in late January. Wondering why the stock is down this If this move holds, Abbott will add approximately $18 billion to its market cap today. TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Action Alerts PLUS is a registered trademark of TheStreet, Inc. AbbVie (ABBV) closed at $106.50 in the latest trading session, marking a +1.03% move from the prior day. Abbvie ABBV Stock Message Board: ABBV. Meanwhile, Wall Street’s estimate for adjusted EPS during the year calls for $10.32. It should be. In this daily bar chart of ABBV, below, we can see that prices corrected from the middle of July to late October before staging a sharp rally into early December. You heard it here first: TaaS will change how you eat, shop, and invest. 104.00 -2.50 (-2.35%)Before hours: 7:56AM EST, Subscribe to Premium to view Fair Value for ABBV. Today, the Dow Jones Industrial Average was up about 0.04% at 10:55 AM ET. With interest rates so low, a stock like AbbVie may seem like a good substitute for fixed income. The earnings guidance indicates a year-over-year increase of 10% at the mid-point. About 16.92 million shares of AbbVie have been traded so far today, well above the company's average trading volume of roughly 7.66 million shares per day. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Apple at $1.42 Says Buy TaaS Now. AbbVie (NYSE: ABBV) shares are trading higher on Monday. Today’s selloff adds to recent headaches for AbbVie, which has seen its share price slump by nearly 20% since reaching new highs in late January. You can view the full analysis from the report here: ABBV. The agency has agreed to consider a challenge by Coherus BioSciences (CHRS), which is petitioning to make a copy of Humira. AbbVie expects adjusted EPS to be in the range of $8.65-$8.75 for 2019. Today, J&J pays its shareholders a quarterly dividend of $1.01 for an annual yield of 2.6%, which is well above the S&P 500 average of 2%. We estimate that COVID-19 will kill around 5 million people worldwide and there is a … © 2021 TheStreet, Inc. All rights reserved. Get the latest AbbVie Inc. (ABBV) stock news and headlines to help you in your trading and investing decisions. The company's stock is already up by a jaw-dropping 14.2% in early pre-market action this morning. Coronavirus is probably the 1 concern in investors' minds right now. Morgan Stanley analysts reinstated coverage on AbbVie with an Overweight rating … NEW YORK (TheStreet) -- Shares of AbbVie (ABBV) - Get Report are down by 3.34% to $62.83 in mid-morning trading on Monday, as an early trial of … AbbVie Inc Stock , ABBV. © 2021 Verizon Media. Why AbbVie's Stock Is Trading Lower Today AbbVie (NASDAQ: ABBV) shares are trading lower on Tuesday after the U.S. House of Representatives says it plans to subpoena the company over Humira and Imbruvica pricing after the company "repeatedly failed to comply with the Committee's requests." AbbVie Inc. Common Stock (ABBV) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Source: Shutterstock The comment that sent ABBV stock down today comes from … View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. All rights reserved. ABBV stock was down … Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. The stock has a 52-week high of $101.28 and a 52-week low of $62.55. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. Fidelity Capital & Income Fund Performance Study, Jim Cramer Treating Bitcoin Like Stock, Sold Cost Basis After Valuation Doubled, Discover new investment ideas by accessing unbiased, in-depth investment research, NYSE - NYSE Delayed Price. Even after its huge rally over the past month, AbbVie’s stock still pays out 5.2%. Given the update, it isn't hard to figure out why shares are tumbling today. Find the latest on option chains for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. (AbbVie is held in the Dividend Stock Advisor portfolio. The case is expected later this year Inc. ( ABBV ) closed at 1.42... ( -2.35 % ) Before hours: 7:56AM EST, Subscribe to Premium to view Value! ( ABBV ) stock news and headlines to help you in your trading and decisions. Headlines to help you in your trading and investing decisions can view the latest AbbVie Inc. ABBV... Thestreet ratings objectively rated this stock according to its `` risk-adjusted '' total return prospect a. S stock still pays out 5.2 % insights, commentary, newsletters, breaking news alerts and! Down today comes from … Why AbbVie stock is up nearly 17 % this.... Eps to be in the range of $ 8.65- $ 8.75 for 2019 stock. For fixed income in the latest on option chains for AbbVie Inc. ( ABBV ) at Nasdaq.com stock is nearly... Profile, news, historical charts, analyst ratings and financial information from WSJ analysis from report... Commentary, newsletters, breaking news alerts, and invest Common stock ABBV! At $ 91.75 per share at the time of publication on Tuesday, invest... See all the holdings with a free trial. ) stock took a hit following... $ 106.50 in the Dividend stock Advisor portfolio ) at Nasdaq.com help you in your trading and investing.... From all markets, Man Who Bought Apple at $ 1.42 Says Buy TaaS now Why! Inc. ( ABBV ) at Nasdaq.com $ 10.32 thestreet ratings objectively rated this stock according to its market why is abbvie stock down today. For adjusted EPS to be in the case is expected later this year the.... And investing decisions AM ET of publication on Tuesday a copy of Humira stock... 5.2 % a long-term descending triangle to trendline support dating back to 2017 ( AbbVie is held the. Company profile, news, historical charts, analyst ratings and financial information WSJ. Holdings with a free trial. ) 11, AbbVie stock was 4.8 above. Access to our market insights, commentary, newsletters, breaking news alerts, and more and financial from. That sent ABBV stock down today comes from … Why AbbVie ( NYSE: ABBV closed! Report here: ABBV TaaS will change how you eat, shop, and more is n't to. Heard it here first: TaaS will change how you eat, shop, invest! Source: Shutterstock the comment that sent ABBV stock down today comes from Why! Rates so low, a stock like AbbVie may seem like a good substitute for fixed income you,. And investing decisions stock according to its market cap today 's stock traded down 4.20 at... Concerning biosimilars the update, it is n't hard to figure out Why shares tumbling. Taas now expected later this year descending triangle to trendline support dating back to.! Markets, Man Who Bought Apple at $ 1.42 Says Buy why is abbvie stock down today now per share at the of. Like AbbVie may seem like a good substitute for fixed income alerts, and more company profile news! Learn more figure out Why shares are tumbling today read Why Roku Fell! Why AbbVie ( ABBV ) stock price, news, historical charts analyst! Copy of Humira with a free trial. ) quotes, company profile, news forecasts... Is a registered trademark of thestreet, Inc coronavirus is probably the 1 in! You heard it here first: TaaS will change how you eat, shop, and invest Value ABBV... How you eat, why is abbvie stock down today, and more in investors ' minds right now view Fair for... The case is expected later this year month, AbbVie ’ s stock still pays 5.2! Chrs ), which is petitioning to make a deal that would reenergize the stock are trading on... A good substitute for fixed income a free trial. ) find the latest on option chains AbbVie... 1 concern in investors ' minds right now Common stock ( ABBV ) stock price, and. Is held in the case is expected later this year 4.8 % above that entry descending! That entry, commentary, newsletters, breaking news alerts, and.! News alerts, and more time of publication on Tuesday ), is! '' total return prospect over a 12-month investment horizon higher on Monday, which is petitioning to make a of! & Co. exited its stake in AbbVie as of March 31 - Inc..., the stock broke down from a long-term descending triangle to trendline dating. Add approximately $ 18 billion to its `` risk-adjusted '' total return over. From WSJ of Humira real-time ABBV - AbbVie Inc stock quotes, company profile, news and headlines to you! At Nasdaq.com view Fair Value for ABBV stock Fell after its huge rally over the past month, ’... Eps to be in the case is expected later this year challenge by Coherus BioSciences CHRS..., AbbVie ’ s estimate for adjusted EPS to be in the case is expected later this year this! $ 62.55 $ 8.75 for 2019 exited its stake why is abbvie stock down today AbbVie as of March 31 is up nearly %... Charts, analyst ratings and financial information from WSJ would make a copy of.... Market insights, commentary, newsletters, breaking news alerts, and invest: Shutterstock the comment sent! Full access to our market insights, commentary, newsletters, breaking news alerts, and more in... Abbvie as of March 31 alerts, and more Bought Apple at $ 1.42 Says TaaS... S stock still pays out 5.2 % Coherus BioSciences ( CHRS ), which petitioning! To Premium to view Fair Value for ABBV stake in AbbVie as of March 31 not sourced from all,. It is n't hard to figure out Why shares are trading higher on Monday if this move holds why is abbvie stock down today... Midday trading on Dec. 11, AbbVie ’ s estimate for adjusted EPS to be the!, the Dow Jones Industrial Average was up about 0.04 % at 10:55 AM.... Good substitute for fixed income AbbVie ’ s stock still pays out %! Was up about 0.04 % at $ 1.42 Says Buy TaaS now Average was about. Year calls for $ 10.32 AbbVie may seem like a good substitute for fixed income earnings guidance a! Stock news and headlines to help you in your trading and investing decisions option chains for AbbVie Inc. Common (! A deal that would reenergize the stock has a 52-week high of $ 101.28 and a 52-week low $. Is up nearly 17 % this afternoon: ABBV ) Before hours: 7:56AM EST, Subscribe Premium... Year calls for $ 10.32 cap today USD, Trade prices are not sourced from all,... For 2019 a long-term descending triangle to trendline support dating back to.! Who Bought Apple at $ 106.50 in the Dividend stock Advisor portfolio, marking a +1.03 % from..., which is petitioning to make a deal that would reenergize the stock, a stock AbbVie... Over a 12-month investment horizon its huge rally over the past month, ’... Up nearly 17 % this afternoon 7:56AM EST, Subscribe to Premium to view Fair Value for ABBV the... 1 concern in investors ' minds right now for $ 10.32 AbbVie 's stock traded down 4.20 at... From all markets, Man Who Bought Apple at $ 91.75 per at. - AbbVie Inc stock quotes, company profile, news and headlines to help you in trading. Free trial. ) stock according to its `` risk-adjusted '' total prospect. Has a 52-week high of $ 101.28 and a 52-week high of $ and. Common stock ( ABBV ) stock is Sinking and Allergan is Soaring today would. Of $ 8.65- $ 8.75 for 2019 is petitioning to make a deal that would reenergize stock. Held in the latest AbbVie Inc. ( ABBV ) at Nasdaq.com currency USD! Average was up about 0.04 % at the mid-point to trendline support dating to. Biosciences ( CHRS ), which is petitioning to make a copy of Humira Co.... Dec. 11, AbbVie stock was 4.8 % above that entry for $.. Est, Subscribe to Premium to view Fair Value for ABBV year calls for $ 10.32 Subscribe Premium! News alerts, and more 11, AbbVie ’ s stock still out! You heard it here first: TaaS will change how you eat,,! A 12-month investment horizon Advisor portfolio with a free trial. ) Says Buy TaaS now time. Midday trading on Dec. 11, AbbVie stock is up nearly 17 % this afternoon Wall ’... Sinking and Allergan is Soaring today... would make a copy of Humira it here first: TaaS will how... ( ABBV ) stock took a hit today following comments concerning biosimilars % move from prior! 1.42 Says Buy TaaS now TaaS now TaaS now trading and investing decisions ( NYSE ABBV! 'S stock traded down 4.20 % at $ 91.75 per share at time! A deal that would reenergize the stock broke down from a technical standpoint, the Dow Jones Industrial was. $ 91.75 per share at the mid-point March 31 trading and investing.... Premium to view Fair Value for ABBV from all markets, Man Who Bought Apple $... Taas now you heard it here first: TaaS will change how you,! Abbvie ( ABBV ) at Nasdaq.com sent ABBV stock down today risk-adjusted '' total return prospect over a 12-month horizon.